Biotech entrepreneur George Church launches gene therapy startup to design safer viral vectors

Biotech entrepreneur George Church launches gene therapy startup to design safer viral vectors

Source: 
Fierce Biotech
snippet: 

Adeno-associated viruses have become popular vectors for the delivery of gene therapies. But, despite their relatively safe profile, they can trigger some unwanted immune responses, which may reduce treatment efficacy or, worse, cause serious side effects.